Status:
COMPLETED
Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Hypertension
Hyperlipidemia
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
To evaluate efficacy of the dual therapy of atorvastatin + amlodipine vs. amlodipine alone .
Eligibility Criteria
Inclusion
- Subjects with a diagnosis of both hyperlipidemia and hypertension.
Exclusion
- Subjects with Type 1 diabetes mellitus or Type 2 diabetes mellitus.
- Subjects with other atherosclerotic disease.
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
End Date :
February 1 2006
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT00174330
Start Date
May 1 2005
End Date
February 1 2006
Last Update
January 27 2021
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Beijing, Beijing Municipality, China, 100044
2
Pfizer Investigational Site
Guangzhou, Guangdong, China, 510080
3
Pfizer Investigational Site
Guangzhou, Guangdong, China, 510100
4
Pfizer Investigational Site
Guangzhou, Guangdong, China, 510515